GSK-205235

Study Sponsor: GSK

Study Title

A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Medicine or Vaccine (generic name)

Trivalent Group B streptococcus Vaccine

Sponsor Identification Number

205235

Trial Registry Identification Number(#'s)

NCT02046148

Medical Condition

Streptococcus agalactiae

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205235

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02046148

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study.

Date Added to this Site

November 2020